Total Payments
$471,101
2024 Payments
$20,468
Companies
20
Transactions
650
Medicare Patients
12,112
Medicare Billing
$556,230
Payment Breakdown by Category
Other$411,964 (87.4%)
Travel$45,363 (9.6%)
Food & Beverage$12,749 (2.7%)
Consulting$985.00 (0.2%)
Education$40.55 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $411,964 | 194 | 87.4% |
| Travel and Lodging | $45,363 | 184 | 9.6% |
| Food and Beverage | $12,749 | 265 | 2.7% |
| Consulting Fee | $985.00 | 2 | 0.2% |
| Education | $40.55 | 5 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amarin Pharma Inc. | $210,720 | 254 | $0 (2021) |
| Amgen Inc. | $138,461 | 198 | $0 (2023) |
| Esperion Therapeutics, Inc. | $104,900 | 117 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $15,298 | 21 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $684.42 | 10 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $201.58 | 11 | $0 (2023) |
| CVRx, Inc. | $147.99 | 3 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $147.09 | 9 | $0 (2023) |
| PFIZER INC. | $75.65 | 5 | $0 (2022) |
| Merck Sharp & Dohme LLC | $70.94 | 4 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $20,468 | 25 | Esperion Therapeutics, Inc. ($20,412) |
| 2023 | $1,825 | 15 | Esperion Therapeutics, Inc. ($830.00) |
| 2022 | $46,700 | 86 | Esperion Therapeutics, Inc. ($25,784) |
| 2021 | $43,112 | 58 | Esperion Therapeutics, Inc. ($39,507) |
| 2020 | $57,396 | 66 | Amarin Pharma Inc. ($23,182) |
| 2019 | $110,999 | 130 | Amarin Pharma Inc. ($78,495) |
| 2018 | $80,059 | 115 | Amarin Pharma Inc. ($60,596) |
| 2017 | $110,542 | 155 | Amarin Pharma Inc. ($48,433) |
All Payment Transactions
650 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/07/2024 | TriSalus Life Sciences, Inc. | TRINAV INFUSION SYSTEM (Device) | Food and Beverage | In-kind items and services | $30.83 | General |
| Category: ONCOLOGY | ||||||
| 07/03/2024 | Esperion Therapeutics, Inc. | NEXLIZET (Drug), NEXLETOL | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,480.00 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 07/03/2024 | Esperion Therapeutics, Inc. | NEXLIZET (Drug), NEXLETOL | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,480.00 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 06/27/2024 | Esperion Therapeutics, Inc. | NEXLIZET (Drug), NEXLETOL | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,480.00 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 06/27/2024 | Esperion Therapeutics, Inc. | NEXLIZET (Drug), NEXLETOL | Travel and Lodging | In-kind items and services | $980.50 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 06/27/2024 | Esperion Therapeutics, Inc. | NEXLIZET (Drug), NEXLETOL | Food and Beverage | In-kind items and services | $113.97 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 06/26/2024 | Esperion Therapeutics, Inc. | NEXLIZET (Drug), NEXLETOL | Travel and Lodging | In-kind items and services | $1,415.50 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 06/26/2024 | Esperion Therapeutics, Inc. | NEXLIZET (Drug), NEXLETOL | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 06/19/2024 | Esperion Therapeutics, Inc. | NEXLIZET (Drug), NEXLETOL | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,030.00 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 06/19/2024 | Esperion Therapeutics, Inc. | NEXLIZET (Drug), NEXLETOL | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 06/19/2024 | Esperion Therapeutics, Inc. | NEXLIZET (Drug), NEXLETOL | Travel and Lodging | Cash or cash equivalent | $20.10 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 06/13/2024 | Esperion Therapeutics, Inc. | NEXLIZET (Drug), NEXLETOL | Travel and Lodging | Cash or cash equivalent | $338.78 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 06/13/2024 | Esperion Therapeutics, Inc. | NEXLIZET (Drug), NEXLETOL | Travel and Lodging | In-kind items and services | $198.69 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 06/13/2024 | Esperion Therapeutics, Inc. | NEXLIZET (Drug), NEXLETOL | Food and Beverage | In-kind items and services | $123.97 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 06/13/2024 | Esperion Therapeutics, Inc. | NEXLIZET (Drug), NEXLETOL | Food and Beverage | Cash or cash equivalent | $15.00 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 04/20/2024 | Esperion Therapeutics, Inc. | NEXLIZET (Drug), NEXLETOL | Travel and Lodging | In-kind items and services | $622.21 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 04/20/2024 | Esperion Therapeutics, Inc. | NEXLIZET (Drug), NEXLETOL | Travel and Lodging | Cash or cash equivalent | $393.98 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 04/20/2024 | Esperion Therapeutics, Inc. | NEXLIZET (Drug), NEXLETOL | Travel and Lodging | In-kind items and services | $257.09 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 04/20/2024 | Esperion Therapeutics, Inc. | NEXLIZET (Drug), NEXLETOL | Food and Beverage | In-kind items and services | $97.41 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 04/20/2024 | Esperion Therapeutics, Inc. | NEXLIZET (Drug), NEXLETOL | Travel and Lodging | Cash or cash equivalent | $70.55 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 04/20/2024 | Esperion Therapeutics, Inc. | NEXLIZET (Drug), NEXLETOL | Food and Beverage | In-kind items and services | $46.43 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 04/20/2024 | Esperion Therapeutics, Inc. | NEXLIZET (Drug), NEXLETOL | Food and Beverage | In-kind items and services | $40.97 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 04/20/2024 | Esperion Therapeutics, Inc. | NEXLIZET (Drug), NEXLETOL | Food and Beverage | Cash or cash equivalent | $7.24 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 04/10/2024 | Esperion Therapeutics, Inc. | NEXLIZET (Drug), NEXLETOL | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,950.00 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 01/01/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $24.51 | General |
| Category: Heart Failure and Hypertension | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 2,920 | 3,543 | $407,133 | $139,796 |
| 2022 | 11 | 3,046 | 3,625 | $379,012 | $133,426 |
| 2021 | 16 | 2,953 | 3,423 | $382,826 | $138,728 |
| 2020 | 17 | 3,193 | 3,598 | $382,299 | $144,280 |
Total Patients
12,112
Total Services
14,189
Medicare Billing
$556,230
Procedure Codes
59
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 521 | 897 | $228,934 | $79,349 | 34.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 146 | 146 | $48,892 | $16,732 | 34.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 212 | 216 | $29,535 | $10,458 | 35.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 65 | 69 | $26,581 | $9,042 | 34.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 1,213 | 1,421 | $25,239 | $8,590 | 34.0% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Facility | 2023 | 200 | 200 | $15,819 | $5,128 | 32.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 460 | 487 | $16,027 | $4,900 | 30.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 22 | 24 | $8,658 | $3,217 | 37.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 22 | 24 | $4,328 | $1,523 | 35.2% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Office | 2023 | 45 | 45 | $2,430 | $627.44 | 25.8% |
| 93272 | Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | Office | 2023 | 14 | 14 | $690.00 | $229.73 | 33.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 469 | 774 | $198,380 | $69,695 | 35.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 134 | 134 | $45,301 | $15,622 | 34.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 272 | 277 | $38,805 | $13,815 | 35.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 1,384 | 1,619 | $27,523 | $9,876 | 35.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 43 | 48 | $17,429 | $6,323 | 36.3% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Facility | 2022 | 210 | 210 | $16,978 | $6,277 | 37.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 33 | 33 | $13,002 | $4,885 | 37.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 418 | 446 | $14,150 | $4,432 | 31.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 26 | 26 | $4,734 | $1,513 | 32.0% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Office | 2022 | 31 | 32 | $1,376 | $469.07 | 34.1% |
| 93272 | Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | Office | 2022 | 15 | 15 | $751.00 | $293.70 | 39.1% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2022 | 11 | 11 | $583.00 | $225.49 | 38.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 379 | 617 | $159,302 | $57,963 | 36.4% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2021 | 311 | 318 | $45,090 | $16,828 | 37.3% |
About Dr. Khalid Sheikh, MD
Dr. Khalid Sheikh, MD is a Cardiovascular Disease healthcare provider based in Melbourne, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1639278427.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Khalid Sheikh, MD has received a total of $471,101 in payments from pharmaceutical and medical device companies, with $20,468 received in 2024. These payments were reported across 650 transactions from 20 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($411,964).
As a Medicare-enrolled provider, Sheikh has provided services to 12,112 Medicare beneficiaries, totaling 14,189 services with total Medicare billing of $556,230. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Melbourne, FL
- Active Since 09/21/2006
- Last Updated 12/05/2024
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1639278427
Products in Payments
- Vascepa (Drug) $210,720
- Repatha (Biological) $138,363
- NEXLIZET (Drug) $104,793
- ENTRESTO (Drug) $15,269
- PRADAXA (Drug) $567.62
- XARELTO (Drug) $201.58
- ELIQUIS (Drug) $165.53
- Barostim Neo System (Device) $147.99
- JARDIANCE (Drug) $116.80
- NEXLETOL (Drug) $107.06
- VERQUVO (Drug) $70.94
- PRALUENT (Drug) $63.03
- BRILINTA (Drug) $52.13
- LifeVest (Device) $47.56
- Corlanor (Drug) $47.36
- Kerendia (Drug) $44.32
- CHANTIX (Drug) $42.25
- TRINAV INFUSION SYSTEM (Device) $30.83
- LEQVIO (Drug) $29.55
- PRALUENT ALIROCUMAB INJECTION (Biological) $24.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Melbourne
Dr. Kevin Campbell, M.d, M.D
Cardiovascular Disease — Payments: $111,606
Cardiovascular Disease $111,606
Enrique Polanco, Md, MD
Cardiovascular Disease — Payments: $27,873
Cardiovascular Disease $27,873
Charles Croft, Md, Facp, Facc, MD, FACP, FACC
Cardiovascular Disease — Payments: $19,989
Cardiovascular Disease $19,989
Dr. Hany Guirgis, M.d, M.D
Cardiovascular Disease — Payments: $11,620
Cardiovascular Disease $11,620
Thomas Swain, Md, MD
Cardiovascular Disease — Payments: $10,022
Cardiovascular Disease $10,022
Rakesh Patel, Md, MD
Cardiovascular Disease — Payments: $8,864
Cardiovascular Disease $8,864